Prolife at ESH 2025: Advancing Cardiovascular Care on a Global Scale

At ESH 2025, Prolife unveiled a major public health initiative as part of the Tools for Doctors program — a GLOBAL SCREENING CAMPAIGN targeting blood pressure and atrial fibrillation (AFIB). These two conditions are among the four major modifiable risk factors for stroke — and can now be detected together in a single, quick, and painless measurement.

This combined screening is not only clinically impactful but also the most accessible and cost-effective diagnostic action in global healthcare today. It's a practical, scalable solution that can transform how communities worldwide prevent strokes and manage cardiovascular risk.

The initiative sparked strong engagement from leading experts and organizations, including KOLs from WHL, ESH, ISH, and several national hypertension leagues — all of whom recognized its simplicity, value, and potential for massive health system impact.

Central to this effort is the PX7 Premium, our flagship BP monitor, purpose-built for home use and population screening. It incorporates critical components of the Tools platform, including:

- AFIB Smart Technology – a state-of-the-art system for the early detection of atrial fibrillation, enabling timely risk identification and proactive care.
- Artificial Intelligent measurement (AIm) Technology – AI-powered algorithms that deliver unparalleled accuracy and reliability in blood pressure monitoring.
- Intelligent Assistant – a user-centric interface that simplifies self-monitoring while upholding clinical precision.

Through Tools for Doctors, we are expanding the role of digital diagnostics from point-of-care support to community-wide prevention.

We thank all the clinicians, researchers, and public health leaders who visited us at ESH 2025. Together, we are building the future of proactive, preventive cardiovascular care.

Together, we are not only advancing technology — we are saving lives.

Trust the Best!